home / stock / drna / drna quote
Last: | $38.22 |
---|---|
Change Percent: | 0.58% |
Open: | $38.21 |
Close: | $38.22 |
High: | $38.24 |
Low: | $38.21 |
Volume: | 5,540,025 |
Last Trade Date Time: | 12/27/2021 04:55:08 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$38.22 | $38.21 | $38.22 | $38.24 | $38.21 | 5,540,025 | 12-27-2021 |
$38 | $38.04 | $38 | $38.16 | $37.97 | 2,386,618 | 12-24-2021 |
$38 | $38.04 | $38 | $38.16 | $37.97 | 2,377,842 | 12-23-2021 |
$38.06 | $38.1 | $38.06 | $38.13 | $38.04 | 2,172,828 | 12-22-2021 |
$38 | $38 | $38 | $38 | $37.815 | 2,568,312 | 12-21-2021 |
$37.98 | $37.92 | $37.98 | $38.04 | $37.84 | 2,289,010 | 12-20-2021 |
$37.81 | $38.03 | $37.81 | $38.06 | $37.8 | 6,498,294 | 12-17-2021 |
$38 | $37.96 | $38 | $38.065 | $37.89 | 3,798,781 | 12-16-2021 |
$38.05 | $37.97 | $38.05 | $38.15 | $37.845 | 3,476,276 | 12-15-2021 |
$37.91 | $37.83 | $37.91 | $38.235 | $37.82 | 2,312,001 | 12-14-2021 |
$37.89 | $37.84 | $37.89 | $38.1 | $37.83 | 2,584,915 | 12-13-2021 |
$37.91 | $38 | $37.91 | $38 | $37.78 | 2,767,631 | 12-10-2021 |
$37.92 | $38.02 | $37.92 | $38.14 | $37.92 | 2,338,809 | 12-09-2021 |
$38 | $38.05 | $38 | $38.1 | $38 | 1,991,555 | 12-08-2021 |
$38.16 | $38.16 | $38.16 | $38.23 | $38.14 | 2,785,865 | 12-07-2021 |
$38.18 | $38.13 | $38.18 | $38.26 | $38.1 | 2,585,778 | 12-06-2021 |
$38.25 | $38.18 | $38.25 | $38.265 | $38.06 | 3,960,891 | 12-03-2021 |
$38.12 | $38.02 | $38.12 | $38.24 | $38.01 | 3,184,083 | 12-02-2021 |
$38.1 | $38.01 | $38.1 | $38.19 | $38 | 3,476,096 | 12-01-2021 |
$38.01 | $38.1 | $38.01 | $38.16 | $37.96 | 5,428,852 | 11-30-2021 |
News, Short Squeeze, Breakout and More Instantly...
Dicerna Pharmaceuticals Inc. Company Name:
DRNA Stock Symbol:
NASDAQ Market:
Dicerna Pharmaceuticals Inc. Website:
Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), announced on 18 November 2021, has been completed. Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has today acquired all outstan...
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Easter...
Direxion Launches mRNA ETF (MSGR) MSGR Offers Exposure to Rapidly Evolving mRNA Sector PR Newswire NEW YORK , Dec. 9, 2021 /PRNewswire/ -- Direxion announced today the launch of the Direxion mRNA ETF (Ticker: MSGR) . MSGR invests in companies ...